cephalosporin c has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abril-Pérez, C; Botella-Estrada, R; Roca-Ginés, J; Sánchez-Arráez, J; Torres-Navarro, I | 1 |
1 other study(ies) available for cephalosporin c and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Biopsy, Needle; Cephalosporins; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Severity of Illness Index; Treatment Outcome | 2020 |